Science

CONTEC Co.,Ltd Demonstrates Capabilities in Private Ground Station Services Through Communication with 'Daejeon Sat'

CONTEC Co.,Ltd. Successfully Establishes Communication with 'DaejeonSat' via Its Own Ground Station

Kang Min-koo
2026-10-26 13:02:18
[Edaily Reporter Kang Min-koo ] Contact Co., Ltd. ( CONTEC Co.,Ltd(451760)), a company specializing in space ground station services, successfully transmitted and received data from the “DaejeonSAT-1” satellite using its own infrastructure, demonstrating its technical capabilities in private space infrastructure.

CONTEC Co.,Ltd announced on the 26th that it had established two-way communication between “DaejeonSAT-1”—which entered orbit via the Korean-developed Nuri launch vehicle on the 7th—and a ground station it built and owns.

CONTEC Co.,Ltd Jeju Asian Space Park. (Photo courtesy of CONTEC Co.,Ltd)

CONTEC Co.,Ltd is the only South Korean company specializing in global space ground station services, operating a network of 16 ground stations across 11 countries worldwide, including Jeju. As the focus of the space industry is rapidly shifting from hardware (launch vehicles and satellites) manufacturing to service areas such as data reception, processing, and utilization, the value of a seamless network capable of handling the surge in low-Earth orbit satellites is growing increasingly important. This success demonstrates that CONTEC Co.,Ltd.’s ground station infrastructure has entered the operational phase.

In particular, this communication demonstrated the capabilities of a private ground station by supporting the operation of an in-orbit satellite using only CONTEC Co.,Ltd.’s proprietary infrastructure, thereby breaking free from dependence on overseas ground stations.

“DaejeonSat” is a satellite project launched with the aim of enhancing Korea’s self-reliance in space technology and broadening the base of the space industry ecosystem. Immediately after the satellite reached its orbit, two-way communication with CONTEC Co.,Ltd’s ground station began. Subsequently, initial core communication processes—such as receiving status information and transmitting ground operation commands—were carried out flawlessly.

Drawing on its extensive experience in satellite communications both domestically and internationally, CONTEC Co.,Ltd provided support for core technologies ranging from the initial communication phase to orbital data processing and signal acquisition.

The success of a space mission hinges on maintaining a “stable data pipeline” between the satellite in orbit and the ground following launch. Contech handled the initial communication and status verification procedures using its own infrastructure.

A CONTEC Co.,Ltd official stated, “CONTEC Co.,Ltd has proven that it possesses world-class capabilities to reliably provide advanced communication services to satellites in actual orbit, going beyond its ground station engineering capabilities,” adding, “Moving forward, we will leverage our proprietary ground station network to provide differentiated services to domestic and international satellite operators and take the lead in strengthening the global competitiveness of the private space industry.”

Economy

Corporation

IT·Science

Economy

Samsung INICS Corporation Awaits ‘Record-Breaking Earnings’… Will It Unveil More Shareholder Returns?

Expectations are growing for additional shareholder returns from SamsungElectronics and SK hynix ahead of their upcoming record-breaking earnings announcements. This comes as the two companies’ combin…
2026-10-26 16:04:59

Corporation

Engineering Job Postings Rise 14-Fold… Wanted Lab Inc. Helps Match Talent

Wanted Lab Inc.(376980)is hosting an in-person job fair to directly connect developers with companies in response to growing demand for "Chonbang Engineers" (FDE). Photo courtesy of WantedLab Inc.…
2026-10-26 15:07:27

IT·Science

SillaJen, Inc.’s BAL0891 Demonstrates Anticancer Efficacy at the European Society for Medical Oncology Conference… Response Rate of 21.4% in Combination Therapy Group

SillaJen, Inc.(215600)has confirmed initial antitumor effects in a Phase 1 clinical trial of its new anticancer drug candidate, “BAL0891,” currently under development. In an interim analysis of patien…
2026-10-26 15:11:02